Return to content in this issue

Excipients as potential agents of anaphylaxis in vaccines: analyzing the formulations of the current authorized COVID-19 vaccines

Caballero ML, Quirce S

Department of Allergy, La Paz University Hospital, IdiPAZ, Madrid, Spain.

J Investig Allergol Clin Immunol 2021; Vol. 31(1)
doi: 10.18176/jiaci.0667